Published in Lancet on October 22, 1966
Intensive hospital monitoring of adverse reactions to drugs. Br Med J (1969) 12.09
Adverse reactions to drugs in general practice. Br Med J (1979) 2.02
Adverse drug reactions during hospitalization. Can Med Assoc J (1967) 2.01
Detection of drug-induced disease. Br J Clin Pharmacol (1979) 1.56
Recognition of unwanted drug effects. Br Med J (1969) 1.35
Adverse drug reactions during treatment of hypertension. Drugs (1976) 1.23
Computer analysis of epidemiologic data on effect of drugs on hospital patients. Public Health Rep (1969) 1.19
Evaluation of haptoglobin phenotype 0-0 in cirrhotic and non-cirrhotic hospital populations. J Clin Pathol (1970) 0.91
Drug surveillance data in a Canadian hospital. Can Med Assoc J (1976) 0.86
Clinical pharmacology. Drug monitoring. Br Med J (Clin Res Ed) (1981) 0.79
Hypertension. The true incidence of side-effects. J R Coll Gen Pract Occas Pap (1980) 0.75
Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history. J R Soc Med (2009) 0.75
Monitoring adverse reactions to antibiotics in general practice. J Epidemiol Community Health (1982) 0.75
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature (2001) 42.18
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA (1992) 22.27
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med (1992) 17.33
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med (1978) 15.13
Getting to grips with Archie Cochrane's agenda. BMJ (1992) 14.05
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Measuring the quality of medical care. A clinical method. N Engl J Med (1976) 11.68
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Meta-analyses of randomized controlled trials. N Engl J Med (1987) 10.37
Randomized versus historical controls for clinical trials. Am J Med (1982) 7.53
A method for assessing the quality of a randomized control trial. Control Clin Trials (1981) 6.63
Perusing the literature: comparison of MEDLINE searching with a perinatal trials database. Control Clin Trials (1985) 6.60
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med (1994) 5.72
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes (1965) 5.42
National Center for Health Statistics: 25 years of service. Public Health Rep (1985) 5.41
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med (1994) 5.04
Antidepressants and suicide. BMJ (1995) 4.84
Bias in treatment assignment in controlled clinical trials. N Engl J Med (1983) 4.78
Randomization of the first patient. Med Clin North Am (1975) 4.69
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Publication bias and clinical trials. Control Clin Trials (1987) 4.34
The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med (1985) 4.08
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA (1996) 3.88
Diet and overall survival in elderly people. BMJ (1995) 3.73
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med (1977) 3.33
The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg (1998) 3.32
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med (1993) 3.27
Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet (1993) 3.24
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol (1992) 3.19
Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA (1994) 3.15
The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med (1996) 3.15
Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness. Ann Intern Med (1995) 3.14
A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14
Vitamin A supplementation and child mortality. A meta-analysis. JAMA (1993) 3.09
Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04
Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med (1983) 3.04
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Women, work and coronary heart disease: prospective findings from the Framingham heart study. Am J Public Health (1980) 2.94
Comprehensive drug surveillance. JAMA (1970) 2.92
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Chlorination, chlorination by-products, and cancer: a meta-analysis. Am J Public Health (1992) 2.86
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
On the feasibility of linking census samples to the National Death Index for epidemiologic studies: a progress report. Am J Public Health (1983) 2.83
Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol (1995) 2.74
An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials (1990) 2.71
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64
A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med (1981) 2.59
A cohort study of summary reports of controlled trials. JAMA (1990) 2.51
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation (1990) 2.51
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors. Am J Epidemiol (1978) 2.47
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
Cancer incidence by levels of cholesterol. JAMA (1981) 2.42
Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA (1988) 2.41
Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation (2000) 2.40
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
The present status of shunts for portal hypertension in cirrhosis. Gastroenterology (1966) 2.38
Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol (1998) 2.38
National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965-1984. Chest (1987) 2.34
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
Measuring the quality of medical care: second revision of tables of indexes. N Engl J Med (1980) 2.34
Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers. JAMA (1990) 2.32
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control (1990) 2.25
Framingham Disability Study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease. Am J Epidemiol (1985) 2.21
A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med (1969) 2.19
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
Postoperative patient-controlled analgesia: meta-analyses of initial randomized control trials. J Clin Anesth (1993) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
Socio-economic factors in the prognosis of cancer patients. J Chronic Dis (1970) 2.10
Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol (1993) 2.07
Findings from the American College of Epidemiology's survey on Ethics guidelines. The American College of Epidemiology Ethics and Standards of Practice Committee. Ann Epidemiol (1998) 2.06